FACULTY
David M. Miller, MD, PhD, FAAD
Director, Center for Merkel Cell Carcinoma
Co-Director, NMSC Multi-Disciplinary Clinic
Massachusetts General Cancer Center
Boston, MA
PROGRAM OVERVIEW
This podcast series will focus on improving the ability of healthcare professionals (HCPs) to accurately assess recurrence risk in the patient with either basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC); increasing communication and coordination for the oncology team to optimize the care of high-risk patients with appropriate use of immune checkpoint therapy in NMSC; and ensuring the consistent application of evidence-based oncology recommendations for patients with either BCC or cSCC for clinicians treating NMSC within the Department of Veterans Affairs.
TARGET AUDIENCE
This activity is designed to meet the educational needs of Veterans Affairs dermatologists, Mohs surgeons, medical oncologists, head and neck surgeons and the multidisciplinary care team who care for Veterans with either basal cell or cutaneous squamous cell carcinomas.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply risk assessment for recurrence to veterans with either cutaneous squamous cell carcinoma or basal cell carcinoma
- Evaluate immunotherapy clinical trials findings for their appropriate application via clinical practice guidelines to patients with either BCC or cSCC
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationships | Manufacturer |
| David M. Miller, MD | Consultant/ Advisory Board | Merck, EMD Serono, Regeneron, Sanofi Genzyme |
| Contracted Research | Regeneron, Kartos Therapeutics, NeoImmune Tech, Inc, Project Data Sphere | |
| Stock Options | Checkpoint Therapeutics, Avstera Therapeutics |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Sylvia Hanna, Medical Services for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: January 02, 2024
EXPIRATION DATE: January 02, 2025
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Vishal Anil Patel, MD
Director, Cutaneous Oncology
George Washington Cancer Center
Director, Dermatologic Surgery
George Washington Department of Dermatology
Associate Professor, Dermatology & Hematology/Oncology
George Washington University School of Medicine & Health Sciences
Washington, DC
PROGRAM OVERVIEW
This podcast series will focus on improving the ability of healthcare professionals (HCPs) to accurately assess recurrence risk in the patient with either basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC); increasing communication and coordination for the oncology team to optimize the care of high-risk patients with appropriate use of immune checkpoint therapy in NMSC; and ensuring the consistent application of evidence-based oncology recommendations for patients with either BCC or cSCC for clinicians treating NMSC within the Department of Veterans Affairs.
TARGET AUDIENCE
This activity is designed to meet the educational needs of Veterans Affairs dermatologists, Mohs surgeons, medical oncologists, head and neck surgeons and the multidisciplinary care team who care for Veterans with either basal cell or cutaneous squamous cell carcinomas.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate immunotherapy clinical trials findings for their appropriate application via clinical practice guidelines to patients with either BCC or cSCC
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationships | Manufacturer |
| Vishal Anil Patel, MD | Consultant | Regeneron, Almirall, Sun Pharma, InflaRx |
| Speakers Bureau | Regeneron, Sanofi | |
| Contracted Research | Regeneron | |
| Ownership Interests | Science 37, Avstera, Thirona |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Sylvia Hanna, Medical Services for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: January 02, 2024
EXPIRATION DATE: January 02, 2025
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Krista M. Rubin, MS, FNP-BC
Nurse Practitioner
Center for Melanoma / Cutaneous Oncology
Massachusetts General Cancer Center
Boston, MA
PROGRAM OVERVIEW
This podcast series will focus on improving the ability of healthcare professionals (HCPs) to accurately assess recurrence risk in the patient with either basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC); increasing communication and coordination for the oncology team to optimize the care of high-risk patients with appropriate use of immune checkpoint therapy in NMSC; and ensuring the consistent application of evidence-based oncology recommendations for patients with either BCC or cSCC for clinicians treating NMSC within the Department of Veterans Affairs.
TARGET AUDIENCE
This activity is designed to meet the educational needs of Veterans Affairs dermatologists, Mohs surgeons, medical oncologists, head and neck surgeons and the multidisciplinary care team who care for Veterans with either basal cell or cutaneous squamous cell carcinomas.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe multidisciplinary collaboration and consultation to the management of patients with either advanced basal cell carcinoma or advanced cutaneous squamous cell carcinoma
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationships | Manufacturer |
| Krista M. Rubin, MS | Nothing to disclose | |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Sylvia Hanna, Medical Services for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: January 02, 2024
EXPIRATION DATE: January 02, 2025
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
